Synthesis, biological evaluation and mechanism of action of benzothiazole derivatives with aromatic hydrazone moiety, a new class of antileishmanial compounds
Chemical Biology & Drug Design · 2024
DOI: 10.1111/cbdd.14585 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von Elaine Soares Coimbra und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Parasitologia, Microbiologia e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Juiz de Fora, Juiz de Fora, Braz…. Hauptthemen laut MEDLINE: Benzothiazoles, Antiprotozoal Agents, Hydrazones, Leishmania. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Leishmaniasis is a disease caused by protozoa Leishmania spp., considered as a significant and urgent public health problem mainly in developing countries. In the absence of an effective vaccine, the treatment of infected people is one of the most commonly prophylactic measures used to control this disease. However, the therapeutic arsenal is reduced to a few drugs, with serious side effects and variability in efficacy. Attempting to this problem, in this work, a series of benzothiazole derivatives was synthetized and assayed against promastigotes and intracellular amastigotes of L . amazonensis , as well as the toxicity on macrophages. In addition, studies about the mechanism of action were also performed. Among the synthesized molecules, the substitution at position 4 of the aromatic ring appears to be critical for activity. The best compound exhibited IC 50 values of 28.86 and 7.70 μM, against promastigotes and amastigotes of L . amazonensis , respectively, being more active than miltefosine, used as reference drug. The in silico analysis of physicochemical and pharmacokinetic (ADMET) properties of this compound suggested a good profile of oral bioavailability and safety. In conclusion, the strategy of using benzothiazole nucleous in the search for new antileishmanial agents was advantageous and preliminar data provide information about the mechanism of action as well as in silico parameters suggest a good profile for preclinical studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Parasitologia, Microbiologia e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Juiz de Fora, Juiz de Fora, Brazil.
- Departamento de Medicina Veterinária, Faculdade de Medicina, Universidade Federal de Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil.
- Fundação Oswaldo Cruz, Instituto de Tecnologia em Fármacos-Far Manguinhos, Rio de Janeiro, Rio de Janeiro, Brazil.
ORCID-Profile: Elaine Soares Coimbra
Zitieren
APA
Coimbra, E. S., Antinarelli, L. M. R., de Oliveira Lemos, A. S., da Silva Neto, A. F., Pinheiro, A. C., & de Souza, M. V. N. (2024). Synthesis, biological evaluation and mechanism of action of benzothiazole derivatives with aromatic hydrazone moiety, a new class of antileishmanial compounds. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14585
Vancouver
Coimbra ES, Antinarelli LMR, de Oliveira Lemos AS, da Silva Neto AF, Pinheiro AC, de Souza MVN. Synthesis, biological evaluation and mechanism of action of benzothiazole derivatives with aromatic hydrazone moiety, a new class of antileishmanial compounds. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14585
BibTeX
@article{Coimbra2024,
author = {Coimbra, Elaine Soares and Antinarelli, Luciana M R and de Oliveira Lemos, Ari Sérgio and da Silva Neto, Adolfo Firmino and Pinheiro, Alessandra Campbell and de Souza, Marcus Vinícius Nora},
title = {Synthesis, biological evaluation and mechanism of action of benzothiazole derivatives with aromatic hydrazone moiety, a new class of antileishmanial compounds},
journal = {Chemical Biology & Drug Design},
year = {2024},
doi = {10.1111/cbdd.14585}
}
EUVIMED